Rare genetic deafness: genes and variants

Explore variant evidence for Rare genetic deafness across 14 analyzed proteins (GJB2, MYO7A, SLC26A4, MYO15A, TECTA and 9 more). Linked ClinVar records include 84 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 13 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Rare genetic deafness

Weakly linked (only a few uncertain records): MITF, EDNRB, HSD17B4 and KCNE1.

ClinVar pathogenic and likely pathogenic variants linked to Rare genetic deafness

VariantPositionProtein partClinical label
GJB2 R32H32TransmembranePathogenic / likely pathogenic (★★★★)
GJB2 R32C32TransmembranePathogenic / likely pathogenic (★★★★)
MYO6 H246R246Myosin motorPathogenic / likely pathogenic (★★★★)
GJB2 A40E40TransmembranePathogenic / likely pathogenic (★★)
GJB2 R184Q184ExtracellularPathogenic / likely pathogenic (★★)
GJB2 A40G40TransmembranePathogenic / likely pathogenic (★★)
GJB2 V84L84TransmembranePathogenic / likely pathogenic (★★)
GJB2 M93I93TransmembranePathogenic / likely pathogenic (★★)
GJB2 C169Y169ExtracellularPathogenic / likely pathogenic (★★)
MYO7A S1471P1471FERM 1Pathogenic / likely pathogenic (★★)
SOX10 W142R142HMG boxPathogenic / likely pathogenic (★★)
GJB2 G12V12IntramembranePathogenic / likely pathogenic (★★)
GJB2 W77R77TransmembranePathogenic / likely pathogenic (★★)
GJB2 Q80P80TransmembranePathogenic / likely pathogenic (★★)
GJB2 L90P90TransmembranePathogenic / likely pathogenic (★★)
GJB2 V95M95CytoplasmicPathogenic / likely pathogenic (★★)
GJB2 H100Y100CytoplasmicPathogenic / likely pathogenic (★★)
GJB2 S199F199TransmembranePathogenic / likely pathogenic (★★)
MYO15A G1418R1418Myosin motorPathogenic / likely pathogenic (★★)
MYO7A H133Y133Myosin motorPathogenic / likely pathogenic (★★)
MYO7A T165M165Myosin motorPathogenic / likely pathogenic (★★)
MYO7A G214R214Myosin motorPathogenic / likely pathogenic (★★)
MYO7A R1873W1873MyTH4 2Pathogenic / likely pathogenic (★★)
MYO7A P1887L1887MyTH4 2Pathogenic / likely pathogenic (★★)
SLC26A4 G209V209TransmembranePathogenic / likely pathogenic (★★)
SLC26A4 L236P236TransmembranePathogenic / likely pathogenic (★★)
SLC26A4 V239D239TransmembranePathogenic / likely pathogenic (★★)
SLC26A4 E384G384CytoplasmicPathogenic / likely pathogenic (★★)
SLC26A4 T416P416ExtracellularPathogenic / likely pathogenic (★★)
SLC26A4 G497S497TransmembranePathogenic / likely pathogenic (★★)
GJB2 V37F37TransmembranePathogenic / likely pathogenic (★★)
GJB2 R127C127CytoplasmicPathogenic / likely pathogenic (★★)
MYO15A R2204C2204MyTH4 1Pathogenic / likely pathogenic (★★)
MYO7A A26E26Pathogenic / likely pathogenic (★★)
MYO7A L366P366Myosin motorPathogenic / likely pathogenic (★★)
MYO7A G1298R1298FERM 1Pathogenic / likely pathogenic (★★)
EYA1 R440Q440Pathogenic / likely pathogenic (★★)
GJB2 K122I122CytoplasmicPathogenic / likely pathogenic (★★)
GJB2 N206S206TransmembranePathogenic / likely pathogenic (★★)
MYO15A V2697A2697TailPathogenic / likely pathogenic (★★)
MYO15A R2728H2728TailPathogenic / likely pathogenic (★★)
MYO7A R83S83Myosin motorPathogenic / likely pathogenic (★★)
MYO7A R212H212Myosin motorPathogenic / likely pathogenic (★★)
MYO7A G519D519Myosin motorPathogenic / likely pathogenic (★★)
MYO7A E1327K1327FERM 1Pathogenic / likely pathogenic (★★)
MYO7A L1858P1858MyTH4 2Pathogenic / likely pathogenic (★★)
MYO7A R1883Q1883MyTH4 2Pathogenic / likely pathogenic (★★)
OTOF I515T515C2 3Pathogenic / likely pathogenic (★★)
OTOF R1792H1792C2 7Pathogenic / likely pathogenic (★★)
SLC26A4 A411P411ExtracellularPathogenic / likely pathogenic (★★)
SLC26A4 G672E672STASPathogenic / likely pathogenic (★★)
SLC26A4 T721M721STASPathogenic / likely pathogenic (★★)
SLC26A4 D724G724STASPathogenic / likely pathogenic (★★)
TECTA T1866M1866ZPPathogenic / likely pathogenic (★★)
EYA1 L583P583Pathogenic / likely pathogenic (★★)
GJB2 K15T15CytoplasmicPathogenic / likely pathogenic (★★)
MYO7A D218N218Myosin motorPathogenic / likely pathogenic (★★)
PCDH15 R134G134Cadherin 1Pathogenic / likely pathogenic (★★)
TMC1 D572N572CytoplasmicPathogenic / likely pathogenic (★★)
MYO7A M1V1Pathogenic / likely pathogenic (★★)

Showing 60 of 84.

Which prediction tools work for Rare genetic deafness

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Rare genetic deafness

Frequently asked questions

Which genes have records linked to Rare genetic deafness?

This view contains 14 analyzed proteins: GJB2, MYO7A, SLC26A4, MYO15A, TECTA and 9 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 84 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 13 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 155 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center